Mass Torts
Mass Torts Law Blog
New Jersey Ethicon and Johnson & Johnson Hernia Mesh Cases: Parties Move for MCL Designation
Posted in Mass Torts
There is a pending application in the Hernia Mesh litigation in New Jersey state court to have the litigation designated as a multicounty litigation (MCL). An MCL would permit centralized management of all related cases filed throughout New Jersey. The MCL parameters proposed by the application would encompass all cases related sixty-two… Continue reading
New Jersey Abilify Cases Designated As an MCL
Posted in Mass Torts
This month, the New Jersey Supreme Court designated the Abilify litigation in New Jersey a multicounty litigation (MCL). The Notice and Order can be found here: https://www.njcourts.gov/notices/2018/n180510b.pdf. Though Bergen County Superior Court Judge James DeLuca had been overseeing all of the Abilify cases filed in New Jersey, those cases will now be… Continue reading
New Cialis Lawsuit Filed May Just Be the Beginning
Posted in Mass Torts
On February 12th, a man from Arkansas filed a lawsuit against Eli Lily and Co., the manufacturers and distributors of the drug taladalafil, also known commercially as Cialis, alleging that the drug was the cause of his melanoma and that he could have avoided the risk of skin cancer if… Continue reading
Invokana Cases Move Toward Trial in New Jersey
Posted in Mass Torts
As previously discussed, in December 2016, the U.S. Judicial Panel on Multidistrict Litigation ordered Invokana cases consolidated into a Multi-District Litigation (MDL) in the United States District Court, District of New Jersey (MDL 2750). Since the inception of the litigation, more than one thousand cases have been filed in the District of… Continue reading
Diabetes Drug, Victoza, May Have Weight Loss Benefits, but Allegedly Linked to an Increase Risk of Pancreatic Cancer
Posted in Mass Torts
Victoza (liraglutide), an injectable Type II diabetes drug, which works by stimulating insulin production by the pancreas, received approval from the U.S. Food and Drug Administration (“FDA”) in 2010. When taken in high doses (3 milligrams), Victoza, manufactured by Novo Nordisk, has been shown to help individuals lose weight. The… Continue reading
Incretin Mimetics Cases See Signs of New Life on Appeal
Posted in Mass Torts
As we have previously reported, safety concerns regarding incretin mimetics (such as Byetta, Januvia/Janumet and Victoza), led to more than a thousand lawsuits being filed across the country. Reports suggest that people taking the medications for the treatment of Type 2 diabetes may be at an increased risk of developing… Continue reading
New Jersey Abilify Cases: Parties Move for MCL Designation
Posted in Mass Torts
In November 2017, counsel for plaintiffs and defendants in the Abilify litigation in New Jersey state court moved to have the litigation designated as a multicounty litigation (MCL). As the New Jersey judiciary site notes, a “[m]ulticounty litigation may be distinguished from other personal injury claims by several distinct features…. Continue reading
Plavix Decision Raises Questions About Learned Intermediary Doctrine
Posted in Mass Torts
A federal judge in New Jersey recently granted summary judgment to Plavix drug makers Bristol Myers-Squibb Company (“BMS”), Sanofi-Aventis U.S., L.L.C., Sanofi-Aventis U.S., Inc., and Sanofi-Synthelabo, Inc. in a lawsuit alleging that plaintiff’s gastrointestinal bleeding was caused by defendants’ prescription drug Plavix. Plaintiff alleged that she suffered injuries as a… Continue reading
Trump Declares Opioid Epidemic a Public Health Emergency
Posted in Mass Torts
On Thursday, October 26, 2017, President Donald Trump declared the opioid crisis a national health emergency. What is the Opioid Epidemic? From 2000 to 2015, more than half a million people died of drug overdoses across the country and most of those deaths involved opioids, according to the Centers for… Continue reading
New Jersey Files Lawsuit Against Opioid Manufacturer
Posted in Mass Torts
Attorney General Christopher S. Porrino recently announced that New Jersey has filed a lawsuit against Insys Therapeutics, Inc. charging that the company engaged in a “greed-driven campaign of consumer fraud and submission of false claims to health insurers” to increase the market share for its opioid-fentanyl drug, Subsys. What Does New… Continue reading
